Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Resource Type
Article
Authors
Stuart, Arabella S V ; Shaw, Robert H ; Liu, Xinxue ; Greenland, Melanie ; Aley, Parvinder K ; Andrews, Nick J ; Cameron, J C ; Charlton, Sue ; Clutterbuck, Elizabeth A ; Collins, Andrea M ; Darton, Tom ; Dinesh, Tanya ; Duncan, Christopher J A ; England, Anna ; Faust, Saul N ; Ferreira, Daniela M ; Finn, Adam ; Goodman, Anna L ; Green, Christopher A ; Hallis, Bassam ; Heath, Paul T ; Hill, Helen ; Horsington, Bryn M ; Lambe, Teresa ; Lazarus, Rajeka ; Libri, Vincenzo ; Lillie, Patrick J ; Mujadidi, Yama F ; Payne, Ruth ; Plested, Emma L ; Provstgaard-Morys, Samuel ; Ramasamy, Maheshi N ; Ramsay, Mary ; Read, Robert C ; Robinson, Hannah ; Screaton, Gavin R ; Singh, Nisha ; Turner, David P J ; Turner, Paul J ; Vichos, Iason ; White, Rachel ; Nguyen-Van-Tam, Jonathan S ; Snape, Matthew D
Source
In The Lancet 1-7 January 2022 399(10319):36-49
Subject
Primary Research Articles
Language
ISSN
0140-6736